Exposing the potential manipulation of data linking cholesterol to heart disease by pharmaceutical companies, leading to overprescription of statins and a $29 billion industry, questioning c... Read allExposing the potential manipulation of data linking cholesterol to heart disease by pharmaceutical companies, leading to overprescription of statins and a $29 billion industry, questioning claims and motives.Exposing the potential manipulation of data linking cholesterol to heart disease by pharmaceutical companies, leading to overprescription of statins and a $29 billion industry, questioning claims and motives.








